Startups in INCUBA raise over half a billion DKK – INCUBA strengthens access to investors

INCUBA has just completed its annual IMPACT analysis, showing continued progress among companies in the science park despite a market where access to capital remains a significant barrier. In 2025, startups in INCUBA raised more than DKK 555 million in total, while 44% increased their revenue and 40% improved their earnings. At the same time, 52% launched new products.

From research to capital and market

An increasing number of companies in INCUBA are successfully attracting investment and turning advanced technologies into business. Among them are Draupnir Bio, which works with targeted protein degradation and has attracted international investor interest, and Kvantify, which develops quantum technology solutions and raised a significant investment round in 2025.

The companies represent a broad range of industries spanning life science and deep tech to AI and green technology. What they share is a strong knowledge foundation and the ambition to scale internationally.

Closer to investors and competencies

Access to capital is strengthened when founders, investors and competencies are brought together in the same environment. At INCUBA, efforts are focused on bringing these actors closer together – including through INCUBA Next Level, where growth-stage startups and investors meet and collaborate on a daily basis.

Startups in INCUBA are growing – hiring more, developing and launching new solutions

Companies in INCUBA continue to evolve. The new IMPACT analysis for 2025 highlights an environment where growth and stability go hand in hand. 44% of the companies increased their revenue, while 49% maintained their level from the previous year. At the same time, 40% increased their earnings, and 44% hired more employees. In addition, 52% launched new products in 2025.

Aarhus strengthens its position as a biotech hub with new multi-million grant

Aarhus once again demonstrates its strength as an international hub for life science and health innovation. With a new Grand Solutions grant of DKK 24 million from Innovation Fund Denmark for the GENIUS project, INCUBA-based company ARCEDI is taking a significant step toward shaping the future of prenatal diagnostics.

New multi-million grant brings hope for stopping Parkinson’s disease

With a grant of DKK 26.7 million from the Innovation Fund Denmark for the DESYNA project, INCUBA-based company Draupnir Bio is taking an important step towards developing a new type of treatment for Parkinson’s disease. The project is carried out in collaboration with Aarhus University and aims to develop therapies that can remove and prevent the spread of a harmful protein in the brain – the underlying cause of the disease.

Startups in INCUBA look to growth – but also point to new challenges

Companies in INCUBA are entering 2026 with clear ambitions for growth. At the same time, they highlight a number of challenges that must be addressed to reach the next level. The new IMPACT analysis shows that 54% expect to increase revenue, 43% expect to hire more employees, and 43% expect to improve earnings in the coming year. This indicates continued high ambitions and companies that are ready to take the next step within the environment.

Upcoming events

GIN & TECH

07 May 2026 kl. 15:00 / INCUBA Navitas, Pier Venue

Do you want to share knowledge, experience and networks to help early startups and founders evolve? Then attend our event, Gin & Tech at INCUBA, where startups from INCUBA and the Aarhus Startup community pitch to mentors, investors, business leaders and specialists.

Summer Party 2026

18 June 2026 kl. 17:00 / INCUBA Katrinebjerg

Summer party in INCUBA.

Other news

Community drives growth in INCUBA At INCUBA, it is not only the companies that grow. It is the relationships between them. The new IMPACT analysis for 2025 shows that 44% of companies in INCUBA collaborated with each other over the past year. At the same time, 289 events and networking activities have been held, attracting around 7,000 participants. Read more

Re-Claim secures new funding and takes the next step towards market The startup Re-Claim in INCUBA has raised DKK 1.4 million for pilot production and is now ready to take the next step towards bringing its bark-based building materials to market. Read more

MedicQuant in INCUBA raises DKK 22 million for acute stroke technology MedicQuant has completed the first closing of its seed round at DKK 22 million, led by Delphinus Venture Capital. Read more

Delphinus Venture Capital invests in Kvantify in INCUBA New funding of EUR 7 million will accelerate the development of quantum technology for drug discovery. Read more

LevitaCare from INCUBA Next Level secures investment from Delphinus Venture Capital MedTech startup LevitaCare is addressing an overlooked public health challenge and gains momentum with an investment from Delphinus Venture Capital, based in the Investor Hub at INCUBA Next Level. Read more